2017
DOI: 10.23937/2378-3656/1410175
|View full text |Cite
|
Sign up to set email alerts
|

Gaisbock's Syndrome: A Case Study

Abstract: A 57-year-old hypertensive, obese woman presented with several weeks of a febrile flu-like illness, facial and extremity flushing, and laboratory findings of polycythemia. A workup revealed no evidence of polycythemia rubra vera or a secondary cause of her polycythemia (her erythropoietin level was normal, she had no splenomegaly, and a test for JAK2 v617F mutation was negative). Over the next two weeks, her fever subsided, and her hematological profile returned to normal, pre-illness levels. We conclude that … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…A reduction in plasma volume, which can cause relative erythrocytosis, may be present in individuals with hypovolemia (eg, induced by the use of diuretics) or in individuals with Gäisbock's syndrome, which is classically described as erythrocytosis in tense/anxious individuals with hypertension and obesity as risk factors. 30,31 Therefore, as sensitivity analysis, we repeated the analyses in individuals without use of diuretics (ATC code C03) and without metabolic syndrome (defined according to the revised criteria of the National Cholesterol Education Program's Adult Treatment Panel III. 32,33 Odds ratios (ORs) and hazard ratios (HRs) are reported with 95% confidence interval (CI).…”
Section: Data Description and Statistical Analysismentioning
confidence: 99%
“…A reduction in plasma volume, which can cause relative erythrocytosis, may be present in individuals with hypovolemia (eg, induced by the use of diuretics) or in individuals with Gäisbock's syndrome, which is classically described as erythrocytosis in tense/anxious individuals with hypertension and obesity as risk factors. 30,31 Therefore, as sensitivity analysis, we repeated the analyses in individuals without use of diuretics (ATC code C03) and without metabolic syndrome (defined according to the revised criteria of the National Cholesterol Education Program's Adult Treatment Panel III. 32,33 Odds ratios (ORs) and hazard ratios (HRs) are reported with 95% confidence interval (CI).…”
Section: Data Description and Statistical Analysismentioning
confidence: 99%
“…A case report published in 2017 highlighted the use of various antihypertensive agents in the treatment of a 57-year-old white woman with a history of obesity and hypertension controlled with hydrochlorothiazide. 35 This patient presented with a febrile "flulike" illness, facial and extremity flushing, and erythrocytosis (hematocrit 48%, hemoglobin 16.6 gm/dL, RBC count 5.6 million/ µL). She had a negative JAK2 v617F mutation, no splenomegaly, and normal EPO, leukocyte alkaline phosphatase, and vitamin B12 levels.…”
Section: Treatmentmentioning
confidence: 99%